Receive our newsletter – data, insights and analysis delivered to you
  1. News
December 4, 2017

UK’s Medtech Accelerator grants £500k funding for medical technology

The National Health Service (NHS) joint venture (JV) Medtech Accelerator has awarded approximately £500k funding for new medical technology projects in the UK.

The National Health Service (NHS) joint venture (JV) Medtech Accelerator has awarded approximately £500k funding for new medical technology projects in the UK.

Grants between £80,000 and £125,000 each have been made to support development of a safe regional anaesthesia injection system, vacuum therapy for upper gastrointestinal (UGI) tract leaks, a non-invasive diagnostic device for sleep apnoea, and a technology to improve tissue ablation efficacy to destroy tumours.

Medtech Accelerator is a JV between the NHS and regional business partners such as Health Enterprise East (HEE), New Anglia and Greater Cambridge Greater Peterborough (GCGP) Local Enterprise Partnerships (LEPs) and the Eastern Academic Health Science Network (AHSN).

It has been set up to offer funding for early stage development of new medical technologies.

In addition to development of prototypes, the latest grants will be utilised for further technological support, preparing for CE-Mark and conducting clinical trials in humans.

Health Enterprise East CEO Dr Anne Blackwood said: “We are delighted to issue our second round of awards, which when combined with our first round of awards launched earlier this year totals £670k for seven projects – all of which have the potential to become game-changers in the NHS and life-changing for patients.”

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
The powerful networks advancing life sciences in Charleston | USA
The power of infrastructure: How Charleston | SC | USA is expanding horizons for life science companies

The new Safer Injection System for Regional Anaesthesia (SAFIRA) will be developed by Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust and development partner, 42 Technology.

Cambridge University Hospitals NHS Foundation Trust and JEB Technologies are set to develop the endoluminal vacuum device (E-Vac), while Papworth Hospital NHS Foundation Trust and Iceni Labs will develop the non-contact sleep apnoea measurement device.

The new Bimodal Electric Tissue Ablation (BETA) method will be handled by Norfolk and Norwich University Hospital NHS Foundation Trust (NNUH) spin out, Ablatus Therapeutics.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU